Do polymorphisms in the familial parkinsonism genes contribute to risk for sporadic Parkinson's disease?

Movement Disorders

Volumn 24, Issue 6, 2009, Pages 833-838

  Sutherland, Greg T ^a   Halliday, Glenda M ^b   Silburn, Peter A ^a,c   Mastaglia, Frank L ^d   Rowe, Dominic B ^e   Boyle, Richard S ^f   O'Sullivan, John D ^c,g   Ly, Tina ^d   Wilton, Steven D ^d   Mellick, George D ^a,f,g  

^a GRIFFITH UNIVERSITY   (Australia)

^b NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e ROYAL NORTH SHORE HOSPITAL   (Australia)

^f PRINCESS ALEXANDRA HOSPITAL   (Australia)

^g ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Association; Parkinson's disease; PD related genes

Indexed keywords

ADENOSINE TRIPHOSPHATASE 13A2; BETA GLUCOCEREBROSIDASE; GENE PRODUCT; LEUCINE RICH REPEAT KINASE 2; PARKIN; PROTEIN MAPT; PROTEIN NR4A2; PROTEIN PINK1; PROTEIN SNCA; PROTEIN UCHL1; SERINE PROTEINASE OMI; UNCLASSIFIED DRUG;

AGED; ALLELE; ARTICLE; AUSTRALIA; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALPHA-SYNUCLEIN; AUSTRALIA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GLUCOSYLCERAMIDASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MITOCHONDRIAL PROTEINS; ONCOGENE PROTEINS; PARKINSON DISEASE; PARKINSONIAN DISORDERS; POLYMORPHISM, GENETIC; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTON-TRANSLOCATING ATPASES; RETROSPECTIVE STUDIES; SERINE ENDOPEPTIDASES; TAU PROTEINS; UBIQUITIN THIOLESTERASE; UBIQUITIN-PROTEIN LIGASES;

EID: 67651171518     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22214     Document Type: Article

References (32)

1. Barbeau A, Roy M, Cloutier T, et al. Environmental and genetic factors in the etiology of Parkinson's disease. In: Yahr MD, Bergmann KJ, editors. Parkinson's disease advances in neurology. New York: Raven Press; 1987. p 299-306.
2. Doris PA. Hypertension genetics, single nucleotide polymorphisms, and the common disease: common variant hypothesis. Hypertension 2002;39(Part 2):323-331.
3. Farrer M, Maraganore DM, Lockhart P, et al. a-synuclein gene haplotypes are associated with Parkinson's disease. Hum Mol Genet 2001;10:1847-1851.
4. Fung HC, Xiromerisiou G, Gibbs JR, et al. Association of τ haplotype-tagging polymorphisms with Parkinson's disease in diverse ethnic Parkinson's disease cohorts. Neurodegener Dis 2006;3:327-333.
5. Healy DG, Abou-Sleiman PM, Ahmadi KR, et al. NR4A2 genetic variation in sporadic Parkinson's disease: a genewide approach. Mov Disord 2006;21:1960-1963.
6. Healy DG, Abou-Sleiman PM, Ahmadi KR, et al. The gene responsible for PARK6 Parkinson's disease, PINK1, does not influence common forms of Parkinsonism. Ann Neurol 2004;56:329-335.
7. Healy DG, Abou-Sleiman PM, Casas JP, et al. UCHL-1 is not a Parkinson's disease susceptibility gene. Ann Neurol 2006;59: 627-633.
8. Healy DG, Abou-Sleiman PM, Lees AJ, et al. s gene and Parkinson's disease: a case-control study and meta-analysis. J Neurol Neurosurg Psychiatry 2004;75:962-965.
9. Maraganore DM, Wilkes K, Lesnick TG, et al. A limited role for DJ1 in Parkinson disease susceptibility. Neurology 2004;63: 550-553.
10. Paisan-Ruiz C, Lang AE, Kawarai T, et al. LRRK2 gene in Parkinson disease: mutation analysis and case control association study. Neurology 2005;65:696-700.
11. Fung HC, Scholz S, Matarin M, et al. Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol 2006;5: 911-916.
12. Maraganore DM, de Andrade M, Lesnick TG, et al. High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet 2005;77:685-693.
13. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-39.
14. Gartner CE, Battistutta D, Dunne MP, Silburn PA, Mellick GD. Test-retest repeatability of self-reported environmental exposures in Parkinson's disease cases and healthy controls. Parkinsonism Relat Disord 2005;11:287-295.
15. Rocca WA, Maraganore DM, McDonnell SK, Schaid DJ. Validation of a telephone questionnaire for Parkinson's disease. J Clin Epidemiol 1998;51:517-523.
16. Xia Y, Rohan de Silva HA, Rosi BL, et al. Genetic studies in Alzheimer's disease with an NACP/a-synuclein polymorphism. Ann Neurol 1996;40:207-215.
17. The International HapMap Consortium. The International Hap-Map Project. Nature 2003;426:789-796.
18. Zhao JH. 2LD, GENECOUNTING and HAP: computer programs for linkage disequilibrium analysis. Bioinformatics 2004;20: 1325-1326.
19. Khan N, Graham E, Dixon P, et al. Parkinson's disease is not associated with the combined a-synuclein/apolipoprotein E susceptibility genotype. Ann Neurol 2001;49:665-668.
20. Mellick GD, Maraganore DM, Silburn PA. Australian data and meta-analysis lend support for a-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease. Neurosci Lett 2005;375:112-116.
21. Parsian A, Racette B, Zhang ZH, et al. Mutation, sequence analysis, and association studies of a-synuclein in Parkinson's disease. Neurology 1998;51:1757-1759.
22. Spadafora P, Annesi G, Pasqua AA, et al. NACP-REP1 polymorphism is not involved in Parkinson's disease: a case-control study in a population sample from southern Italy. Neurosci Lett 2003; 351:75-78.
23. Tan EK, Matsuura T, Nagamitsu S, Khajavi M, Jankovic J, Ashizawa T. Polymorphism of NACP-Rep1 in Parkinson's disease: an etiologic link with essential tremor? Neurology 2000;54: 1195-1198.
24. Maraganore DM, de Andrade M, Elbaz A, et al. Collaborative analysis of α-synuclein gene promoter variability and Parkinson disease. JAMA 2006;296:661-670.
25. Goris A, Williams-Gray CH, Clark GR, et al. τ and α-synuclein in susceptibility to, and dementia in, Parkinson's disease. Ann Neurol 2007;62:145-153.
26. Mueller JC, Fuchs J, Hofer A, et al. Multiple regions of a-synuclein are associated with Parkinson's disease. Ann Neurol 2005; 57:535-541.
27. Winkler S, Hagenah J, Lincoln S, et al. α-synuclein and Parkinson disease susceptibility. Neurology 2007;69:1745-1750.
28. Biskup S, Mueller JC, Sharma M, et al. Common variants of LRRK2 are not associated with sporadic Parkinson's disease. Ann Neurol 2005;58:905-908.
29. Paisan-Ruiz C, Evans EW, Jain S, et al. Testing association between LRRK2 and Parkinson's disease and investigating linkage disequilibrium. J Med Genet 2006;43:e9.
30. Kwok JB, Teber ET, Loy C, et al. Tau haplotypes regulate transcription and are associated with Parkinson's disease. Ann Neurol 2004;55(3):329-334.
31. Skipper L, Wilkes K, Toft M, et al. Linkage disequilibrium and association of MAPT H1 in Parkinson disease. Am J Hum Genet 2004;75:669-677.
32. Zabetian CP, Hutter CM, Factor SA, et al. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease. Ann Neurol 2007;62:137-144.